Literature DB >> 16201103

Bacterial infection and acute bleeding from upper gastrointestinal tract in patients with liver cirrhosis.

L Husová1, J Lata, P Husa, M Senkyrík, J Juránková, P Díte.   

Abstract

BACKGROUND/AIMS: Acute bleeding from the upper gastrointestinal tract is a common and serious complication of liver cirrhosis. It is believed that bacterial infection may be the immediate cause of the bleeding and the latest meta-analyses show that bacterial infection is an independent predictive factor of the failure to stop bleeding.
METHODOLOGY: The authors evaluated the presence of bacterial infection (blood, urine, throat and ascitic fluid) in 35 consecutive patients with liver cirrhosis and acute bleeding with portal hypertension and compared these results with a group of 35 patients with liver cirrhosis with portal hypertension without acute bleeding.
RESULTS: According to the results obtained, there is a statistically higher incidence of bacterial infection among patients with acute bleeding with portal hypertension (25 of 35 patients, 71%) than among patients with liver cirrhosis and portal hypertension without acute bleeding (14 of 35 patients, 40%, p < 0.01). The incidence of bacteriological findings in blood and throat samples is statistically higher in patients with acute bleeding as opposed to the control group (p < 0.05).
CONCLUSIONS: These results confirm the necessity of administering antibiotic prophylaxis to all cirrhotic patients with variceal bleeding, not just to those with confirmed infection or symptoms thereof.

Entities:  

Mesh:

Year:  2005        PMID: 16201103

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

Review 1.  Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding.

Authors:  Norberto C Chavez-Tapia; Tonatiuh Barrientos-Gutierrez; Felix I Tellez-Avila; Karla Soares-Weiser; Misael Uribe
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

2.  Gut microbiota of liver transplantation recipients.

Authors:  Li-Ying Sun; Yun-Sheng Yang; Wei Qu; Zhi-Jun Zhu; Lin Wei; Zhi-Sheng Ye; Jian-Rui Zhang; Xiao-Ye Sun; Zhi-Gui Zeng
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.